| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |